VEA
Virtus ETF Advisers Portfolio holdings
AUM
$75.7M
1-Year Return
23.01%
This Quarter Return
+10.19%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$207M
AUM Growth
+$71.8M
(+53%)
Cap. Flow
+$59.1M
Cap. Flow
% of AUM
28.6%
Top 10 Holdings %
Top 10 Hldgs %
47.49%
Holding
157
New
10
Increased
64
Reduced
2
Closed
3
Top Buys
| 1 |
ETP
Energy Transfer Partners L.p.
ETP
|
$6.39M |
| 2 |
WPZ
Williams Partners L.P.
WPZ
|
$5.59M |
| 3 |
BPL
Buckeye Partners, L.P.
BPL
|
$5.03M |
| 4 |
Energy Transfer Partners
ET
|
$3.72M |
| 5 |
Enterprise Products Partners
EPD
|
$3.26M |
Top Sells
| 1 |
Williams Companies
WMB
|
$5.12M |
| 2 |
MDVN
MEDIVATION, INC.
MDVN
|
$546K |
| 3 |
RLYP
RELYPSA INC COM
RLYP
|
$521K |
| 4 |
Targa Resources
TRGP
|
$487K |
| 5 |
United States Oil Fund
USO
|
$16K |
Sector Composition
| 1 | Energy | 63.95% |
| 2 | Healthcare | 21.58% |
| 3 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Enanta Pharmaceuticals
ENTA
$190M
| $709K | 0.34% |
26,649
+3,357
| +14% | +$89.3K |
|
52
United Therapeutics
UTHR
$17.2B
| $685K | 0.33% |
5,804
+731
| +14% | +$86.3K |
|
53
Regeneron Pharmaceuticals
REGN
$60.1B
| $683K | 0.33% |
1,698
+213
| +14% | +$85.7K |
|
54
Amgen
AMGN
$151B
| $679K | 0.33% |
4,071
+514
| +14% | +$85.7K |
|
|
PDLI
55
DELISTED
PDL BioPharma, Inc.
PDLI
| $666K | 0.32% |
198,901
+25,064
| +14% | +$83.9K |
|
|
CLVS
56
DELISTED
Clovis Oncology, Inc.
CLVS
| $644K | 0.31% |
17,865
| – | – |
|
|
MNTA
57
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $644K | 0.31% |
55,093
+6,942
| +14% | +$81.1K |
|
|
MDCO
58
DELISTED
Medicines Co
MDCO
| $644K | 0.31% |
17,070
+2,151
| +14% | +$81.2K |
|
|
CELG
59
DELISTED
Celgene Corp
CELG
| $644K | 0.31% |
6,162
+776
| +14% | +$81.1K |
|
|
MACK
60
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $636K | 0.31% |
12,721
+1,603
| +14% | +$80.1K |
|
61
Omeros
OMER
$284M
| $624K | 0.3% |
55,936
+7,049
| +14% | +$78.6K |
|
62
Vertex Pharmaceuticals
VRTX
$102B
| $594K | 0.29% |
6,814
+859
| +14% | +$74.9K |
|
63
Gilead Sciences
GILD
$140B
| $589K | 0.28% |
7,450
+939
| +14% | +$74.2K |
|
|
ALXN
64
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $581K | 0.28% |
4,745
+598
| +14% | +$73.2K |
|
|
KERX
65
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $562K | 0.27% |
105,877
+13,341
| +14% | +$70.8K |
|
|
ARNA
66
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $556K | 0.27% |
31,763
+4,002
| +14% | +$70.1K |
|
67
Ligand Pharmaceuticals
LGND
$3.27B
| $549K | 0.27% |
8,627
+1,085
| +14% | +$69K |
|
68
Cheniere Energy
CQP
$26.2B
| $515K | 0.25% |
17,587
+5,902
| +51% | +$173K |
|
69
Puma Biotechnology
PBYI
$257M
| $514K | 0.25% |
7,666
| – | – |
|
|
VTAE
70
DELISTED
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
| $512K | 0.25% |
24,463
| – | – |
|
|
ARRY
71
DELISTED
Array Biopharma Inc
ARRY
| $507K | 0.25% |
75,100
| – | – |
|
72
Acadia Pharmaceuticals
ACAD
$4.3B
| $505K | 0.24% |
15,878
+2,001
| +14% | +$63.6K |
|
|
ACOR
73
DELISTED
Acorda Therapeutics, Inc.
ACOR
| $505K | 0.24% |
201
+25
| +14% | +$62.8K |
|
74
PTC Therapeutics
PTCT
$4.61B
| $488K | 0.24% |
34,849
| – | – |
|
75
VanEck Gold Miners ETF
GDX
$19.4B
| $487K | 0.24% |
+18,431
| New | +$487K |
|